Efflux Pumps of Mycobacterium tuberculosis Play a Significant Role in Antituberculosis Activity of Potential Drug Candidates
Meenakshi Balganesh,Neela Dinesh,Sreevalli Sharma,Sanjana Kuruppath,Anju V. Nair,Umender Sharma +5 more
Reads0
Chats0
TLDR
It is shown that these four efflux pump KO mutants of M. tuberculosis play a vital role in mediating efflux of different chemical scaffolds and inhibitors of one or several of these efflux pumps could have a significant impact in the treatment of tuberculosis.Abstract:
Active efflux of drugs mediated by efflux pumps that confer drug resistance is one of the mechanisms developed by bacteria to counter the adverse effects of antibiotics and chemicals. To understand these efflux mechanisms in Mycobacterium tuberculosis, we generated knockout (KO) mutants of four efflux pumps of the pathogen belonging to different classes. We measured the MICs and kill values of two different compound classes on the wild type (WT) and the efflux pump (EP) KO mutants in the presence and absence of the efflux inhibitors verapamil and l-phenylalanyl-l-arginyl-β-naphthylamide (PAβN). Among the pumps studied, the efflux pumps belonging to the ABC (ATP-binding cassette) class, encoded by Rv1218c, and the SMR (small multidrug resistance) class, encoded by Rv3065, appear to play important roles in mediating the efflux of different chemical classes and antibiotics. Efflux pumps encoded by Rv0849 and Rv1258c also mediate the efflux of these compounds, but to a lesser extent. Increased killing is observed in WT M. tuberculosis cells by these compounds in the presence of either verapamil or PAβN. The efflux pump KO mutants were more susceptible to these compounds in the presence of efflux inhibitors. We have shown that these four efflux pumps of M. tuberculosis play a vital role in mediating efflux of different chemical scaffolds. Inhibitors of one or several of these efflux pumps could have a significant impact in the treatment of tuberculosis. The identification and characterization of Rv0849, a new efflux pump belonging to the MFS (major facilitator superfamily) class, are reported.read more
Citations
More filters
Journal ArticleDOI
Synthesis, antibacterial action, and ribosome inhibition of deoxyspectinomycins.
Suresh Dharuman,Laura A. Wilt,Jiuyu Liu,Stephanie M. Reeve,Carl W Thompson,John M Elmore,Dimitri Shcherbakov,Robin B. Lee,Erik C. Böttger,Richard E. Lee +9 more
TL;DR: In this paper, the effects of deoxygenation of the 2-and 6-hydroxy group positions on the spectinomycin actinamine ring are probed to evaluate their relationship to ribosomal binding and the antimicrobial activities of the synthesized analogs.
Journal ArticleDOI
Mycobacterium tuberculosis treatment modalities and recent insights.
TL;DR: This review highlights the current strategies and challenges in treatment, the different antibiotics available, their modes of action, generation and mechanism of drug resistance and recent advances in the intracellular drug delivery using nanoparticles for the treatment of tuberculosis.
Journal ArticleDOI
Metabolite Profiling: A Tool for the Biochemical Characterisation of Mycobacterium sp.
Margit Drapal,Paul D. Fraser +1 more
TL;DR: The use of metabolite profiling independently or in combination with other levels of “-omic” analyses has proven an effective approach to elucidate key physiological/biochemical mechanisms associated with Mtb throughout infection.
Journal ArticleDOI
Drug-resistant tuberculosis viewed from bacterial and host genomes
Imen Ben-Kahla,Sahal Al-Hajoj +1 more
TL;DR: The main and recent findings regarding MTB determinants implicated in the development of drug resistance and human genetic factors that may play a role in TB drug resistance are outlined.
Journal ArticleDOI
Revisiting the β-Lactams for Tuberculosis Therapy with a Compound-Compound Synthetic Lethality Approach.
Shiqi Xiao,Haidan Guo,Warren S. Weiner,Clinton Maddox,Chunhong Mao,Hendra Gunosewoyo,Shaaretha Pelly,E. Lucile White,Lynn Rasmussen,Frank J. Schoenen,Jeffrey Aubé,William R. Bishai,Shichun Lun +12 more
TL;DR: Compound-compound synthetic lethality screening revealed novel small molecules that were capable of potentiating the action of meropenem, presumably via inhibition of the innate resistance conferred by β-lactam accessory proteins.
References
More filters
Journal ArticleDOI
Multidrug-resistance efflux pumps ? not just for resistance
TL;DR: Evidence is presented that multidrug-resistance efflux pumps have roles in bacterial pathogenicity and it is proposed that these pumps therefore have greater clinical relevance than is usually attributed to them.
Journal ArticleDOI
Transcriptional Adaptation of Mycobacterium tuberculosis within Macrophages Insights into the Phagosomal Environment
Dirk Schnappinger,Sabine Ehrt,Martin I. Voskuil,Yang Liu,Joseph A. Mangan,Irene M. Monahan,Gregory Dolganov,Brad Efron,Philip D. Butcher,Carl Nathan,Gary K. Schoolnik +10 more
TL;DR: The microbial transcriptome served as a bioprobe of the MTB phagosomal environment, showing it to be nitrosative, oxidative, functionally hypoxic, carbohydrate poor, and capable of perturbing the pathogen's cell envelope.
Journal ArticleDOI
Clinically Relevant Chromosomally Encoded Multidrug Resistance Efflux Pumps in Bacteria
TL;DR: This review focuses on chromosomally encoded pumps in bacteria that cause infections in humans, and suggests that resistance nodulation division systems are important in pathogenicity and/or survival in a particular ecological niche.
Journal ArticleDOI
Efflux-mediated antimicrobial resistance
TL;DR: Given the clinical significance of multidrug (and drug-specific) exporters, efflux must be considered in formulating strategies/approaches to treating drug-resistant infections, both in the development of new agents less impacted by efflux and in targeting efflux directly with efflux inhibitors.
Journal ArticleDOI
Efflux-mediated drug resistance in bacteria: an update.
Xian-Zhi Li,Hiroshi Nikaido +1 more
TL;DR: The multifaceted implications of drug efflux transporters warrant novel strategies to combat multidrug resistance in bacteria.